Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRG.L Regulatory News (PRG)

  • There is currently no data for PRG

Rule 8.3- Amendment

31 Oct 2007 08:31

UBS AG31 October 2007 This announcement replaces the previous RNS amendment reference 3840G releasedat 15:32 on 25th October 2007. Amendment made to all figures due to a manualerror. All other information remains unchanged. FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATIONName of person dealing (Note 1) UBS AG London Branch Company dealt in Premier Research Group PlcClass of relevant security to which the dealings 1p ordinarybeing disclosed relate (Note 2)Date of dealing 24 OCTOBER 2007 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 0 0.00% 0 0.00%(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal 0 0.00% 0 0.00% (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) (b) Derivatives transactions (other than options) Product name, Long/short (Note Number of securities Price per unit e.g. CFD 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Optionname,e.g. selling, securities price American, date money paid/ call purchasing, to which the European received option varying etc. option etc. per unit relates (Note 5) (Note 7) (ii) ExercisingProduct name, e.g. Number of securities Exercise price per unit (Note 5)call option (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 25 OCTOBER 2007 Contact name NIMISHA SACHDEV Telephone number 020 7568 9289 If a connected EFM, name of offeree/offeror with N/Awhich connectedIf a connected EFM, state nature of connection N/A(Note 10) This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Oct 20078:31 amRNSRule 8.3- Amendment
31st Oct 20078:31 amRNSRule 8.3 - Premier Research
31st Oct 20078:29 amRNSRule 8.3- Premier Research
31st Oct 20078:27 amRNSRule 8.3 - Premier Research
30th Oct 20079:32 amRNSEPT Disclosure
29th Oct 20073:40 pmRNSRule 8.3- (Premier Research)
29th Oct 20078:35 amRNSEPT Disclosure
26th Oct 200712:22 pmRNSRule 8.3- Premier Research Gp
26th Oct 200711:59 amRNSRule 8.3-Premier Research Gp
26th Oct 200710:07 amRNSEPT Disclosure
25th Oct 20073:32 pmRNSRule 8.3- Premier Research Gp
25th Oct 20078:37 amRNSEPT Disclosure
24th Oct 20072:00 pmRNSRule 8.3- Premier Research
24th Oct 20079:45 amRNSEPT Disclosure
23rd Oct 20073:01 pmRNSRule 8.3- Premier Research Gp
23rd Oct 20073:00 pmRNSRule 8.3- premier research
23rd Oct 200711:29 amRNSEPT Disclosure
22nd Oct 20079:07 amRNSEPT Disclosure
19th Oct 20073:26 pmRNSRule 8.3- (Premier Research)
19th Oct 200712:55 pmRNSInterim dividend-Amendment
19th Oct 200710:16 amRNSEPT Disclosure
19th Oct 20077:01 amRNSInterim Dividend
18th Oct 20073:14 pmRNSRule 8.3- Premier Research
18th Oct 20078:20 amRNSEPT Disclosure
18th Oct 20077:02 amRNSInterim Results
17th Oct 200710:08 amRNSEPT Disclosure
16th Oct 200710:23 amRNSEPT Disclosure
16th Oct 200710:11 amRNSNotification of Results
15th Oct 20072:50 pmRNSRule 8.3- Premier Research Gp
15th Oct 20078:57 amRNSEPT Disclosure
12th Oct 200710:59 amRNSRule 8.3- Premier Research Gp
12th Oct 20079:27 amRNSEPT Disclosure
11th Oct 200711:17 amRNSRule 8.3- Premier Research Gp
11th Oct 20079:35 amRNSEPT Disclosure
10th Oct 20072:23 pmRNSRule 8.3- PREMIER RESEARCH
9th Oct 20071:29 pmRNSRule 8.3- Premier Research Gp
9th Oct 20078:23 amRNSEPT Disclosure
8th Oct 20079:48 amRNSEPT Disclosure
5th Oct 200711:57 amRNSRule 8.3- Premier Research
5th Oct 200710:12 amRNSEPT Disclosure
4th Oct 20079:53 amRNSEPT Disclosure
3rd Oct 200712:55 pmRNSEPT Disclosure
2nd Oct 20079:53 amRNSEPT Disclosure
1st Oct 20078:18 amRNSEPT Disclosure
28th Sep 200711:04 amRNSRule 8.3- Premier Research
28th Sep 200710:25 amRNSEPT Disclosure
27th Sep 200712:01 pmRNSRule 8.3- Premier Research Gp
27th Sep 200710:25 amRNSRule 8.3-Premier Research Grp
27th Sep 20079:16 amRNSEPT Disclosure
26th Sep 20079:20 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.